ArticleTranslational cancer research2026

Clinical value and cost-effectiveness analysis of conditionally approved anticancer drugs in China from 2015 to 2023.

Zhiming Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.